Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy
NCT04453917Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Feb 2021
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Single-arm trial in progressive multifocal leukoencephalopathy (PML), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoints: Expression of immune checkpoint molecules on circulating T cells at 6 months, JC viral load at 6 months and 1 more. Started Feb 2021; status: completed.
02
Conditions
progressive multifocal leukoencephalopathy (PML)
Beyond the preview
Go deeper on NCT04453917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04453917.